Occlusion Devices Market Insights To Witness Notable Growth During the Forecast Period 2022-2030

 Occlusion Devices Market – Overview

The growth in the demand for diagnostic has had a beneficial effect on the growth of the market for occlusion devices. Reports that gauge the healthcare industry have been made available by Market Research Future which creates reports on several industry verticals that review the market growth and prospects. The Occlusion Devices Market size is projected to grow USD 2193.98 million at a CAGR of 6.2% in the forecast period 2022-2030.

The rise in heart-related ailments has been identified as a vital factor for the development of the occlusion devices market. The increased prevalence of chronic diseases is also expected to benefit the demand for occlusion devices. Also, an increased pace of improvement in the product design and efficiency of occlusion devices is projected to create favorable opportunities for expansion.

Competitive Analysis

The escalated turnaround in the market is likely to set off new openings for the development of the market. The enhancement in different domestic economies is projected to encourage the progress of the market in the impending period. The ease in accessing key planned opportunities important to consequent stabilization of inflation is projected to generate a promising option for development in the approaching years. In the approaching years, the control exerted by fairly high-income level nations around the world and the likely gains observed towards a few of the currencies around the world is projected to strengthen the fruition of the market in the forecast period. A significant climb in the number of backers in the market is expected to craft an advantageous state of affairs for the evolution of the market in the projected period. The advancement of the market is projected to capture amplified impetus in the coming years chiefly due to the incidence of contributory government plans.

The occlusion devices market players are Acrostak, Cook Group, Angiodynamics, Asahi Intecc, Avinger, Cardinal Health, Edwards Lifesciences,  Terumo Corporation (Japan), Penumbra, Stryker Corporation, Terumo Corporation, B. Braun Melsungen AG (Germany), Abbott Laboratories (U.S.), Medtronic plc (Ireland), MicroPort Scientific Corporation (China) and Meril Life Sciences Pvt. Ltd. (India) to name a few.

Segmental Analysis

The segmental analysis of the occlusion devices market is carried out on the basis of product, region, application, and end-user. Based on the product, the occlusion devices market is segmented into support devices, tubal occlusion devices, support devices, and occlusion removal devices. The embolization devices segment is further segmented into tubal occlusion devices and liquid embolic agents. The occlusion removal devices are further segmented into stent retrievers, coil retrievers, balloon occlusion devices, and suction and aspiration devices. The support devices segment is further segmented into guidewires and microcatheters. The segmentation of the occlusion devices market based on application comprises of cardiology, neurology, peripheral vascular diseases, oncology, urology, gynecology, and others. The end-user based segmentation of the occlusion devices market comprises of diagnostic centers, hospitals and clinics, ambulatory care centers, surgical centers, and others.

Detailed Regional Analysis     

The regional analysis of the occlusion devices market insights observes that the North American region is the chief region and is chiefly motivated by the mounting patient population suffering from persistent diseases, rising investment in healthcare, and escalating geriatric population levels. Also, the U.S. is the principal market in the North American region due to the incidence of a huge number of market companies manufacturing occlusion devices and growing awareness about risk factors for chronic diseases. The European region’s occlusion devices market shows positive growth with an escalating emphasis on the diagnosis of chronic diseases and other associated diseases. The Asia Pacific region is anticipated to be the top growing market whose expansion is accredited to the mounting burden of chronic diseases and escalating focus on early diagnosis and management of heart diseases. Additionally, other factors contributing to the expansion of the occlusion devices market are lifestyle changes, the control of western culture among adults, and compulsion to smoke. The Middle Eastern and African region in the market for occlusion devices displays a stable rise with a boost in the number of healthcare facilities offering treatment of chronic circumstances and the affluent growth in the medical device sector, particularly in the devices used in treatment methods.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Gastric Bypass Market Players, Outlook, Trends, Size, Share, Scope, Regional Demand and Forecast To 2030

 

Market overview

Gastric bypass is one of the vastly studied surgeries that can even benefit offering several positive effects in the treatment of blood pressure, sleep apnea, and certain forms of cancer. This surgery can also impact diabetes treatments and most importantly with a remarkably fast weight reduction.

Acknowledging the rapid expansion, the market is witnessing at present, Market Research Future (MRFR) in its recently published study analysis asserts that the global gastric bypass market size is expected to reach USD 1,466.75 Million by 2030 at 4.90% CAGR during the forecast period 2022-2030.  The extensive uptake of gastric bypass surgery is a major factor driving the growth of the market.

During various types of research conducted on gastric bypass, a drastic reduction (over 90 percent) in new onset type 2 diabetes was found. Also, in other obesity-related conditions assessed it was found that gastric bypass can bring a significant reduction in the occurrence of high blood pressure and dyslipidemia. Such phenomenal outcomes that the surgery offers are acting as major tailwinds pushing the market on the global platform.

Additional factors that are substantiating the growth of the market include the rising prevalence of obesity, diabetes, and cardiovascular disease, leading to increasing the demand for minimally invasive procedures for the treatment. Moreover, increasing adoption of advanced surgical devices across the medical sector is the primary factor fostering the market growth of the market.

On the other hand, factors such as the side effects associated with the gastric bypass surgery such as developing suicidal tendencies are impeding the growth of the market. Nevertheless, factors such as the full-fledged counseling session conducted before and after the surgery to highlight the need for considerable attention to patients’ psychological health, are expected to support the growth of the market, positively influencing the decision for the operation.

Global Gastric Bypass Market – Competitive Analysis

Highly competitive, the gastric bypass market appears fragmented due to the presence of several matured players. These players form a healthy competitive landscape which results in intensifying the completion in the market. Mergers & acquisitions, innovation, and brand reinforcement remain the key trends for leading players.

Major Players:

Global gastric bypass market players include Intuitive Surgical Inc. (US), TransEnterix Inc.  (US), Medtronic (US), USGI Medical Inc. (US), Cousin Biotech (France), ALLERGAN (Republic of Ireland), Johnson & Johnson Services, Inc. (US), Mediflex Surgical Product (US), and GI Dynamics Inc. (US) among others.

Gastric Bypass Market – Segmentations

For ease of understanding, the analysis has been segmented into four key dynamics:

 

By Type                       : Endoscopic Sleeve Gastroplasty and Intragastric Balloon among others.

By Indication              : High Blood Pressure, Heart Disease, Type 2 Diabetes, and Gastroesophageal Reflux Disease among others.

By End-user                : Clinics and Surgical Centers and Hospitals among others.

By Region                   : North America, Asia Pacific, Europe, and the Rest-of-the-World.

 

Gastric Bypass Market – Geographical Analysis

The North America region, heading with the increasing prevalence of obesity and cardiovascular diseases dominates the global gastric bypass market. Factors that are substantiating the growth in the regional market include the presence of well-established market players & manufacturing setups for the surgical devices and the availability of advanced healthcare specialty services.

The U.S. with its well-developed technology and high healthcare expenditure help the region to command the largest market share. Continuing with the same growth trends, the gastric bypass market in North America is expected to retain its dominance throughout the forecast period.

The gastric bypass market insights in the European region accounts for the second-largest market, globally. Factors such as the increasing diabetic population and the extensive research & development activities in the field of gastroenterology led by the availability of funds foster the growth in the regional market. Germany and France backed by the increasing use of minimally invasive surgical procedures in hospitals, and surgical centers account for the significant contributors to the growth of the regional market.   

The Asia Pacific gastric bypass is emerging as a profitable market, globally. Factors such as the vast technological developments are acting as key driving forces behind the growth of the regional market, meeting the demand for technologically advanced devices for minimally invasive surgical procedures. The rapidly improving economy in the region is acting as a major tailwind that is impacting the growth in the regional market, positively.

Also, the availability of the low-cost treatment and drugs is facilitating the needed boost to the market growth, meeting the large unmet clinical needs of the vast population. Furthermore, factors such as the increasing occurrences of diabetes and cardiovascular diseases and the rising number of specialty services, provide impetus to the market growth to an extent.

Simultaneously, the growing penetration of healthcare insurance mainly in Thailand, Malaysia, and Vietnam alongside the other South East Asian countries are expected to drive the gastric bypass market in the APAC region.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Laboratory Information Systems Market Insights To Witness Notable Growth During the Forecast Period 2022-2030

 

Market Scenario

The global laboratory information systems size is projected to grow USD 3.8694 billion by 2030 at CAGR of 9.50% during the forecast period 2023-2030, predicts Market Research Future (MRFR). There are several practice applications of an LIS that improve the day-to-day operations of a medical laboratory, along with prevention of medical errors. A busy medical laboratory having many patients on a regular basis encounter difficulty in keeping all the patients’ information organized. Thus, an LIS system comes in handy, as it helps keep all this information organized, which is vitally important for a medical lab to run smoothly. Apart from this, rising integration of LIS and Electronic Health Record (EHR) and demand for quality and precision diagnosis are majorly supplementing the market growth globally. Moreover, increasing penetration of mobile applications in healthcare solutions coupled with growing popularity of cloud-based laboratory information system testifies for the market progress that has taken place in the past few years.

On the flip side, lack of skilled information technology (IT) professionals in the healthcare industry tames the flow of the progressing market. However, an array of opportunities stemming from emerging regions along with the consistently growing adoption of LIS are proof enough that the global market is en-route to brighter future prospects. Also noteworthy are few trends that bestow the global market with the required push, including proliferation of smartphones, point-of-care devices and e-services in the healthcare industry which significantly shape the market dynamics. Also, immense demand from patients for technological solutions for more convenient health testing, and monitoring is growing. This leads to global market players taking notice of the opportunities that crop up and indulge in strategic activities such as product launches. For instance, in the year 2014, Thermo Fisher launched a new ultracentrifuge which combines speed with safety and ergonomics that allows researchers to protect samples easily while also achieving reliable and consistent results.

Key Players

global laboratory information systems market players include   Cerner Corporation, Recent Developments, Eclipsys Corporation, Merge Healthcare Inc., STARLIMS Corporation, Sunquest Corporation and Thermo Fisher Scientific Inc., LabVantage Solutions Inc., LabWare Inc., McKesson Corporation, Medical Information Technology Inc., and others.

The Cerner EHR project is thriving as the U.S. Department of Defense increases its budget by about USD 1.2 billion. The additional funds will support the added services to maintain a standard EHR between the Department of Veterans Affairs and the U.S. Coast Guard. The EHR when integrated with laboratory information system, turns highly efficient, which leads to increased productivity and also reduced probability of errors. Cerner is an established company in the global LIS market that understands this fact and makes use of every opportunity to enhance its products to cater to various customer needs.

Market Segmentation

The global market of laboratory information systems is segmented on the basis of application, components, and delivery.

By applications, the market is segmented based on clinical LIS, drug discovery LIS, and industrial LIS. The clinical application of LIS holds the largest market share as using LIS software involves more productivity and less paperwork, enhanced patient safety, and improved turn-around time.

By components, the market is segmented based on software, hardware, and services. Among these, the software segment accounts for the majority of the global LIS market due to increasing product enhancements and advent of innovative LIS software systems which ensures the smooth running of the healthcare department.

By delivery, the market is segmented on the basis of web-based, on-premise and cloud-based. Among these, cloud-based LIS software is highly popular as it offers various benefits such as cost savings, high security, flexibility, mobility and quality control.

Regional Analysis

By region, the global laboratory information systems market insights is segmented on the basis of North America, Europe, Asia Pacific and the Rest of the World (RoW).

The joint market share combining North America and Europe was more than 75% of the global total market size in 2014. However, North America has currently secured the top position claiming the largest market share. This stupendous growth can be attributed to increasing cases of fatal diseases and subsequent diagnostic and treatment needs. Moreover, high disposable income and strong economy also help augment the market growth in the region. Furthermore, increasing business opportunities for healthcare service providers along with growing demand for automated instruments rising in laboratories has majorly triggered the market growth in the region.

On the other hand, the Europe LIS market is estimated to grow tremendously during the forecast period, due to massive investment by healthcare IT players and a barrage of players trying to enter the regional market and establish themselves. Moreover, thriving healthcare industry and sophisticated medical infrastructure also play a major role in the growth of the regional market.

The Asia-marked Pacific is also presumed to grow at a significant pace throughout the forecast period. This growth is due to increased infectious diseases, significant increase in healthcare expenditure and advancements in healthcare IT sector. The market growth in the region is also aided by growing need for enhancing the efficiency of medical laboratories, growing demand for error-free diagnosis and increasing integration of information system with laboratories.

The rising aging population and increasing cases of fatal diseases in the regions of Middle East and Africa have propelled the market growth in the region. Also, the market in the region is highly fragmented, and the regional market players used various strategies such as product launches, expansions, and joint ventures to increase their footprint in the region. This gives a significant push to the market and will continue to do so in the coming years as well.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Hemifacial Spasm Market Players, Outlook, Trends, Size, Share, Scope, Regional Demand and Forecast To 2030

 

Market overview

According to a report published by Market Research Future (MRFR), the global hemifacial spasm market size is projected to reach USD 3170 million by 2030 at a CAGR of 5.4% over the forecast period of 2022 to 2030.

Hemifacial spasm is a painless neurological disorder consisting of persistent or fleeting involuntary contractions or twitches of the muscles innervated by the touching of a blood vessel to a facial nerve, or due to a facial nerve injury, or in severe cases, a tumor.

The influential factors driving the growth of the global hemifacial spasm market is the improvement of the healthcare sector globally, owing to the developing economic conditions, government efforts such as favorable regulations and expenditure towards research and development for providing better healthcare facilities, and the growing awareness among consumers regarding healthcare.

Additionally, technological advancements in medical science have risen the chances of treatment for almost all disorders.

On the other hand, challenges faced by the global hemifacial spasm market are the cost of treatment, side effects of the botulinum toxin which is used during treatment, and the presence of counterfeit drugs or treatment methods.

Key Players

global hemifacial spasm market players are US WorldMeds (U.S.), Abbott (U.S.), Cephalon Inc. (U.S.), Shire plc (U.S.), Stryker (U.S.), Sunovion Pharmaceuticals, Inc. (U.S.), Pfizer (U.S.), Revance Therapeutics, Inc. (U.S.), Johnson & Johnson Services, Inc. (U.S.), Valeant Pharmaceuticals International, Inc., (Canada), GlaxoSmithKline plc (UK), Merz Pharma GmbH and Co. KGaA (Germany), Sanofi S.A (France), UCB S.A. (Belgium), Ipsen Group (France), Novartis AG (Switzerland), Allergan, Inc. (Ireland), Roche (Switzerland), Medytox,Inc. (South Korea), and LLC. (UAE).

Segmental Analysis

The global hemifacial spasm market is segmented on the basis of diagnosis, treatment, end user, and region.

Based on the diagnosis, the market has been segmented into magnetic resonance imaging (MRI), angiography (arteriography), computed tomography (CT or CAT scan), and others.

Based on treatment, the hemifacial spasm market insights has been segmented into medical treatment, surgical treatment, physical therapy, combinational therapy, transcutaneous electric nerve stimulation (TENS) therapy, and others. The medical treatment segment has been sub-segmented into Botulinum Neurotoxin (BoNT) injections, and pharmaceuticals.  The surgical treatment is sub-segmented into microvascular decompression (MVD), and others.

Based on end-users, the market for hemifacial spasm has been segmented into hospitals, clinics, diagnostic centers, drug stores, pharmacies, and others.

Based on regions, the market has been segmented into the Americas, Europe, Asia Pacific, and the Middle East And Africa.

Regional Analysis

The Americas are the largest regional market for hemifacial spasms and are assessed to account for the leading market share over the forecast period. North America is the hub for technological advancements, and the governments provide favorable regulations and expenditure towards the development of the healthcare sector, consequently driving the growth of the hemifacial spasm market in the region.

Europe has the second highest market share and is estimated to be a lucrative region over the forecast period for the hemifacial spasm market due to the investments made by the governments towards research and development for healthcare and improving reimbursement policies, and the presence of significant market players.

The Asia Pacific has been accounted for the fastest growing region in the global hemifacial spasm market and has been estimated to witness substantial growth over the forecast period, owing to the rise in the patient population, and the development of healthcare sector across emerging economies such as China, India and Japan.

The middle east and Africa is an emerging region in the global hemifacial spasm market and is expected to showcase slow, gradual growth over the forecast period.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Oxygen Therapy Equipment Market Insights To Witness Notable Growth During the Forecast Period 2022-2030

 

Market scenario-

Market Research Future (MRFR's) latest report on the global oxygen therapy equipment market size projected to grow USD 34.72 billion by 2030 and capture a CAGR of 5.86% over the forecast period of 2022-2030. Oxygen therapy, also known as O2 therapy, is administered to patients suffering from various respiratory disorders, which provides extra oxygen to keep the patient stable. A range of oxygen therapy equipment are available in the market and are used as per individual patient's requirement. A constant rise in the occurrence rate of life-threatening respiratory devices has propelled the demand for oxygen therapy equipment.

Oxygen therapy equipment have become more efficient and robust in recent years, backed by technological advancements. Besides, improving reimbursement schemes are have also increased the adoption of these devices. Medical device manufacturers are increasingly outlaying massive amounts on R&D activities, which can further the growth of the market over the forecast period. New and innovative products are continually being developed and brought to the marketplace by the key market players. Moreover, these devices have become easily accessible, which is also signaling growth within the market. Furthermore, the market is anticipated to benefit from the consolidating trend of home healthcare, where these devices are extensively used. However, the high developmental cost of these devices and strict regulatory environment governing the medical device industry pose a threat to the market growth. Additionally, frequent alteration in regulations also hinders the growth of the market.

Competitive Landscape

Oxygen therapy equipment market players are Messer Medical Austria GmbH, Esex Industries, Inc., Linde Healthcare (A Division of Linde Group), Allied Healthcare Products Inc., Fisher & Paykel Healthcare Corporation Limited, Medicop D.O.O, Taiyo Nippon Sanso Corporation, Teleflex Incorporated, Invacare Corporation, Becton Dickinson and Company, Smiths Medical (A Division of Smiths Group PLC), Drägerwerk AG & Co. KGaA, and Philips Healthcare (A Division of Koninklijke Philips N.V.) are the key players in the oxygen therapy equipment market.

Segmentation

The oxygen therapy equipment market has been segmented based on product, portability, application, and end-users.

By product, the oxygen therapy equipment market has been segmented into oxygen source equipment, oxygen delivery devices. The oxygen source equipment segment has been further segmented into oxygen concentrators, liquid oxygen devices, and oxygen cylinders. The oxygen concentrators sub-segment has been further segmented into portable oxygen concentrators and fixed oxygen concentrators. The oxygen delivery devices segment has been further segmented into bag valve masks, venturi masks, oxygen masks, non-rebreather masks, nasal cannulas, and other devices.

By portability, the oxygen therapy equipment market has been segmented into stationary oxygen therapy devices and portable oxygen therapy devices.

By application, the oxygen therapy equipment market has been segmented into cystic fibrosis, asthma, COPD, pneumonia, respiratory distress syndrome, and other diseases.

By end-user, the oxygen therapy equipment market has been segmented into home care settings, hospitals, ambulatory surgical centers & physician offices, and others.

 

Regional Analysis

Region-wise, the oxygen therapy equipment market insights has been segmented into the Americas, the Middle East & Africa (MEA), Asia Pacific (APAC), and Europe.

The Americas is at the forefront of the global oxygen therapy equipment market. The presence of a massive patient population suffering from diseases such as COPD, pneumonia, and other respiratory disorders induce high demand for oxygen therapy equipment in the region. High healthcare expenditure in the developed economies of the region combined with favorable reimbursement policies is spurring the growth of the market. The US and Canada are the key contributors to the Americas market.

Europe is following the Americas' lead. Factors such as high government support and increasing incidence rate of respiratory devices are boosting the growth of the market.

The APAC oxygen therapy equipment market is likely to be driven by factors such as the surging prevalence of respiratory disorders, rising government support, high healthcare expenditure in the emerging economies, increased adoption rate, and improving reimbursement landscape.

The MEA market accounts for the least share of the global oxygen therapy equipment market. The majority of the market share is held by the Middle East, where a developed sector and high healthcare expenditure by the GCC countries is boosting the market growth. Concurrently, low healthcare penetration, and poor economic condition hinder the growth of the market.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Cell Culture Media Market Players, Outlook, Trends, Size, Share, Scope, Regional Demand and Forecast To 2030

 Cell Culture Media Market Overview:

The global cell culture media market size is projected to reach USD 5814.62 million by 2030 at a  9.80% CAGR during the forecast period 2022-2030. Over that period, it can also scale and surpass a valuation of USD 1290.1 million, reveals Market Research Future (MRFR). Cell culture media market is having a great run in the biotechnological sector owing to its prevalent use in the growth of microorganisms, cell lines, and cells. Available either in liquid or in gel form, the medium contains amino acids, inorganic salts, vitamins, glucose, serum, and other vital nutrients. However, the traction it is getting is mostly from the healthcare sector where it is often used to develop vaccines. The report includes detailed segmental analysis and description of factors that can impact the market the most. The keen interest shown by the biotechnological firms in studying plants and animals to develop drugs can be considered as a major factor. In healthcare, the demand for the customized drug is getting stronger by day which can spark further researches. In addition, it is the interest shown by governments that is influencing the market considerably.

On reverso, the cell culture media market can face certain blows owing to the considerable investment associated with it. The process incurs a massive cost which prevents smaller economies from participating in such researches. However, the growing involvement of India and China is saving the day. These two regions have relatively less workforce and establishment cost, which is making them alluring in the eyes of market titans who are now expanding their business in the region.

Cell Culture Media Market Competitive Analysis:

Cell culture media market players are HiMedia Laboratories (India), Thermo Fisher Scientific (U.S.), BD Biosciences (U.S.), Lonza (Switzerland), Corning Incorporated (U.S.), Merck KGaA (Germany), and GE Healthcare (U.S.).

CN Bio has developed a 3D cell culture system, PhysioMimix that allows researchers to set up assays and obtain results in faster. The process would allow scientists to mimic the structure and function of human organs for experiments.

Cell Culture Media Market Segmental Analysis:

The cell culture media market, for better comprehension and predictive analysis, can be segmented by type, application, and end-user.

Based on type, the cell culture media market can be segmented into classical media, chemically defined media, protein-free media, lysogeny broth,serum-free media, and custom media. Lysogeny broth rules the market with 22.5% of the global share. Meanwhile, chemically defined media is touted to clock the fastest CAGR of 9.6% during the forecast period.

Based on application, the cell culture media market includes tissue engineering & biochemistry, cancer research, toxicity testing, drug discovery and drug development, genetic engineering, and stem cell research. With 23.8% of the total market share, drug discovery and drug development segment is treading ahead smoothly.

By end-users, the cell culture media market comprises research laboratories, academic institutes, biotechnology & pharmaceutical companies, and pathology labs. Biotechnology & pharmaceutical companies are leading the market at present with a worth of USD 386.5 million in 2016.

Cell Culture Media Market Regional Analysis:

Based on regional expansion, the cell culture media market insights includes the Americas, Asia Pacific (APAC), Europe, and the Middle East and Africa (MEA).

The Americas has the biggest market, and this can be attributed to their superlative infrastructure, technological brilliance, and eagerness to integrate the latest developments in practice. The considerable patient pool in the region is also providing traction to the market growth. 

Europe is following the lead with great gusto. Increasing investment from the governments is helping the researchers plan accordingly, and the market is growing in sync with them. At the same time, the APAC region is doing a commendable job.  The market titans are engaging themselves in a battle over the APAC market as the region has a less infrastructural cost which makes it easier for others to settle in and do business. 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Endometrial Cancer Market Insights To Witness Notable Growth During the Forecast Period 2022-2030

 

Endometrial Cancer Market Overview:

The global endometrial cancer market size is USD 22187.69 million expecting a robust CAGR 4.20% and a strong market presence during the forecast period 2022-2030 in an all-inclusive study asserts Market Research Future (MRFR). Endometrial cancer is also known as uterine cancer and is the sixth most common cancer in women across the world. The daunting number speaks for itself and promotes the factors that ensure the market growth for endometrial cancer.

Market Dashboard:

The market is witnessing significant funding going into research and developments. For instance, Salk Institutes is getting a sizeable amount of fund from Padres Pedal the Cause. Others are mainly focusing on mergers and acquisitions. Royal Philips acquiring EPD Solutions can be taken exemplary. Boston Scientific has also acquired EMcision, Ltd. 

Global endometrial cancer market players are Pfizer Inc., General Electric Company, Koninklijke Philips N.V., LUPIN, PHYTON, Bayer AG, Celgene Corporation, Johnson & Johnson, CooperSurgical Inc., LiNA Medical USA, Conceptus Inc., Hologic Inc., Karl Storz GmbH & Co. Kg, and Boston Scientific Corporation.

Drivers and Restraints:

Urbanization across the world is experiencing an express speed growth rate owing to which the population is undergoing remarkable lifestyle change. A sedentary lifestyle has become the norm for many, and growing obesity among women is resulting in the rising number of endometrial cancer. Lack of nutritional elements in consumed food and other diseases such as polycystic ovarian syndrome (PCOS) and the ovarian tumor can trigger endometrial cancer.

However, a few factors are currently acting as market irritants such as high diagnostic cost, expensive treatment, and side-effects associated with the procedure. Coupled with these factors, stringent government policies regarding the treatment can also create a bottleneck situation for the market.

Industry Trends:

According to the Journal of Clinical Oncology, researchers of John Hopkins Medicine have found a new way to treat uterine cancer by adding the drug trastuzumab to the chemotherapy regimen of the uterine cancer patients. The drug prolongs the tumor growth process and gives the physicians a better opportunity to cure the patients.     

A new finding by the researchers in Huntsman Cancer Institute (HCI) at the University of Utah reveals that in many uterine cancer tissues steroid and hormone receptors are acting simultaneously causing an escalation in the growth of the tumor.

PapSEEK is a type of liquid biopsy which is now enabling researchers to identify endometrial cancer at a very early stage. The screening procedure is still in its early stage, but it can surely benefit the doctors in diagnosing and treating their patients.

Segmentation:

The global endometrial cancer market can be segmented by diagnosis, treatment, and end-user.

By diagnosis, the market can further be segmented into the pelvic examination, transvaginal ultrasound, endometrial biopsy, dilation and curettage (D&C), and laparoscopy. Endometrial biopsy is very common as the confirmatory test for uterine cancer.

Treatment-based market includes hysterectomy techniques, radiation, hormone therapy, chemotherapy, and palliative care. The hysterectomy techniques category comprises open abdominal hysterectomy, total vaginal hysterectomy, total laparoscopic hysterectomy, and robotic hysterectomy. External radiation and internal radiation (brachytherapy) are part of radiation technology. The hormonal therapy consists progestins, tamoxifen, luteinizing hormone-releasing hormone agonists, and aromatase inhibitors. Chemotherapy can be further sub-segmented into paclitaxel, carboplatin, doxorubicin, and cisplatin and is also the most-used treatment method.

Based on the end-users the market can be segmented into hospitals and clinics, ambulatory surgical centers, diagnostic centers, gynecology centers, feminist health centers, and others.

Regional Analysis:

Region-wise the global endometrial cancer market insights covers the Americas, Europe, Asia-Pacific (APAC), and the Middle East and Africa (MEA).

The Americas are currently holding the largest market share and can continue to do so in the near future. The region is experiencing a growing number of endometrial patients who are spending much on diagnostic and treatment. The region has a well-structured healthcare system and extensive research units who are also contributing significantly to the regional market.

Europe is currently holding the second position in the market. Robust healthcare sector and advanced technologies are supporting the European market for uterine cancer treatment.

The APAC can also witness significant growth in the market owing to rising incidence of cervical cancer in countries such as India and China.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Microdermabrasion Market Players, Outlook, Trends, Size, Share, Scope, Regional Demand and Forecast To 2030

 Global Microdermabrasion Market – Synopsis

Acknowledging kind of the growth the market perceives currently; Market Research Future (MRFR) has recently published a study report giving out the complete market forecast up to 2023. In its analysis, MRFR asserts that the global Microdermabrasion market size projected to reach USD 510.4 Million by 2030 with 8.5% CAGR during 2022-2030.

Microdermabrasion or microderm is a technique of exfoliation with the use of a machine to improve health and appearance of skin by sloughing off dead skin cells, allowing new cells to the surface. Considered as a non-invasive treatment Microdermabrasion is safe for individuals with all skin types and textures. However, Microdermabrasion treatment is generally used to remove various types of scars caused due to hyperpigmentation, acne & Trauma, Photo-Damage, and Stretch Marks, among others.

Scars, especially on the face affect a person’s appearance and hence personality, further making the person vulnerable to lose the self-confidence. With the rapid urbanization and increasing access to the improved healthcare, which is fuelled by the improving economic conditions, people are becoming conscious about their appearance. To refine their looks, they increasingly opt for Microdermabrasion. Augmenting uptake is the key factor for the growth of Microdermabrasion market.

With the extensive research in the field, this treatment has become safer and effective to remove the scar. Manufacturers involved in the medical or these machines, strive to develop new and innovative products continually, which can provide advanced solutions to the scar removal, easing the processes further. Additionally, factors contributing the market growth include growing population & urbanization worldwide. Improving economic conditions, globally, are providing impetus to the market growth, increasing consumers’ purchasing power.

On the hand, factors such as the availability of alternative treatments such as chemical peel and laser skin resurfacing coupled with the increasing uptake of the laser resurfacing treatment are impeding the market growth.

Global Microdermabrasion Market – Competitive Landscape

The rapidly growing market for Microdermabrasion is fiercely competitive and fragmented with many well-established as well small & new entrants forming the competitive edge. Innovation, new technology launch and Brand reinforcement remain the popular trends for the key players in the market. The growth statistics of the Scar market presage the probable heights the market can reach further.

Microdermabrasion Market players including Procter & Gamble, Johnson & Johnson Services Inc., Koninklijke Philips N.V., Silhouet-Tone, Altair Instruments, Advanced Microderm, Inc., New Shining Image LLC., Dermaglow, Lasertec Medical Service, and Delasco, lead the global Microdermabrasion market. Profiling them in its analysis MRFR finds out their strategies keeping them at the forefront of the market competition.

Global Microdermabrasion Market – Segments

MRFR has segmented the Microdermabrasion market into Four key dynamics: -

By Types                     : Comprising Diamond Microdermabrasion, and Crystal Microdermabrasion, among others.

By Products    : Microdermabrasion Machine (table top, hand-held, others.), Microdermabrasion Crystals (aluminium oxide crystals, sodium bicarbonate crystals, sodium chloride crystals, others.), Microdermabrasion Tips (diamond tips, bristle tips, others.), Microdermabrasion Creams and Scrubs, among other.

By Indications             : Hyperpigmentation, Acne & Trauma Scars, Photo-Damage, and Stretch Marks, among others.

 

By End Users        : Dermatology Clinics, Hospitals and Home Care, among others.

By Regions                 :  North America, Europe, APAC and Rest of the World.

Global Microdermabrasion Market – Geographical Analysis

Globally North America market dominates the Microdermabrasion market insights with the largest share owing to the presence of numerous facilities and availability of treatments for acne & trauma scar removal. Other factors such as increasing uptake of advanced technologies to address various dermal conditions like stretch marks, acne, and hyperpigmentation, among others, are substantiating the market growth. Owing to the rising demands for minimally invasive procedures, the North America market is expected to create a larger revenue pocket in the global market by 2023. The US, backed by the high expenditure on healthcare coupled with the increasing demand for Microdermabrasion treatments, accounts for the major contributor to the market growth.

Whereas Europe accounts for the second largest market for Microdermabrasion, globally, attributing to the recent advancements in the technology coupled with the augmenting uptake of the technology in the region.  Additionally, the presence of huge patient population and rising healthcare expenditure facilitates the regional market growth.

The Asia-Pacific market is emerging as the rapidly growing market for Microdermabrasion due to the increasing prevalence of acne and the development of related technologies mainly in the countries such as India, China, and Japan. Backed by the rising demand for minimally invasive procedures and increasing adoption of the technologies for Scar removal, APAC market is expected to register a phenomenal CAGR during the forecast period.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

E-Prescribing Systems Market Players, Outlook, Trends, Size, Share, Scope, Regional Demand and Forecast To 2030

 

Market Scenario

Market Research Future (MRFR), in its latest “E-Prescribing Systems Market” report, reveals various factors that are expected to write various factors that can control the growth course of the market. MRFR finding states that the global e-prescribe systems market size is projected to reach USD 1.76 billion by 2030 at 23.4% CAGR during the forecast period 2022-2030. The surge in need for providing better quality patient care is expected prompt the e-prescribing systems market size to increase. Practitioners and pharmacists are being highly benefitted by electronic prescription, which can promote the growth of the e-prescribing systems global market in the years to come. E-prescribing technology improves patient safety and enable easy access to patient medical history that can benefit in the correct choice for treatment regime. Thus, it can be concluded that the market of e-prescribing can thrive in coming years. In addition, increase in incentive programs launched by global governments to improve healthcare quality, cut healthcare expenses, and reduce prescription inaccuracies are causing surge in the adoption of e-prescription systems.

Key Players                                                                                                        

Global e-prescribing systems market players are; Cerner Corporation, Aprima, Practice Fusion, Inc., eClinicalWorks, Surescripts, Allscripts, eMDs, Inc., Athena health Inc., iMedX Inc., and Henry Schein e-prescribe. Competitiveness among prominent players of the market can favor the global e-prescribing systems market to earn considerable turnover. MRFR report can assist key players to design strategies that can allow them to stay ahead of the progress curve.

Segmental Study

The e-prescribing systems market study can be segmented by mode of delivery, system type, end users, and component. Segmental insights of the e-prescription systems market can assist venture capitalist to discern areas for investment to yield substantial revenue. 

The system type-based segments of the market are integrated system and stand-alone system. The integrated system segment can win considerable profits for the e-prescription systems global market.

The mode of delivery-based segments of the market are web-based, cloud-based, and on-premise. Cloud-based e-prescription systems are likely to gain popularity in years to come, which can boost the market growth.

The component-based segments of the market are software, services, and hardware. Marketers are investing in the development of effective and smart e-prescription software.

The end user-based segments of the market are clinics, hospitals, and pharmacy. The immense benefits offered by e-prescriptions to its end-users can favor the market.

Regional Analysis

North America e-prescription systems market insights can secure the pole position globally. In the US, the surge in initiatives and funding by the government body can authorize the availability of potential scope of the e-prescribing systems market to surge. The availability of modern technical infrastructure can spur the expansion of the regional market.

Europe e-prescription systems market health to improve in the years to come. EU market can be benefitted by the rise in healthcare based projects and the availability of robust healthcare networks. The need to curb healthcare expenditure and the existence of medical infrastructure empowered with latest medical technologies are other driver of the EU e-prescribing systems market.

Asia Pacific e-prescribing systems market growth is likely to be expedited due to rise in the number of healthcare organizations, developing healthcare programmes, and launch of projects that can enhance patient safety and care. The growing inclination towards digitization to eliminate frauds and human errors, increase in healthcare expenditure, and the adoption for latest technologies can fuel the market growth.

The MEA e-prescribing systems market is expected for a slow growth through the study period. Lack of awareness about patient management software and limited access to modern treatment facilities can hinder the regional market growth.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Capillary Blood Collection Devices Market Players, Outlook, Trends, Size, Share, Scope, Regional Demand and Forecast To 2030

 Market Summery

Acknowledging the impressive growth records, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global Capillary Blood Collection Devices market size will register a staggering CAGR of 5.70% from 2022-2030, witnessing the accruals of approx. 778.38 Mn. USD by 2030.

Capillary Blood Collection Devices, the equipment used to collect the blood samplings for diagnosis and test purposes are integral to obtain high-quality clinical results. These devices are vastly preferred among clinicians and patients due to its simple and painless blood collection technique. 

Growing prevalence of chronic diseases and disorders such as vascular, diabetes, and heart diseases drive the market growth, increasing the demand for diagnosis and the uptake of these devices.  Resultantly, the global capillary blood collection devices market is garnering huge traction, growing pervasively.

Undoubtedly, technological advancements transpired in the field of medical devices as a foray to bring more innovations in these devices are boosting the market growth, escalating the market to the exceeding heights.

Conversely, high prices of these devices is a predominant factor impeding the market growth. Also, the risk associated with the blood collection techniques and contaminations are hampering the market growth of the capillary blood collection devices market. Nevertheless, recent betterments taken place in these devices as a result of forays of the market players are increasing the demand for these devices by the physicians and patients, contributing to the market growth to a great extent, in turn.

Capillary Blood Collection Devices Market – Competitive Landscape

The global market appears to be highly competitive and diversified with the presence of giant manufacturers of the devices, playing on the global level. These players are heavily investing in R&D, global expansion, advanced technologies and product Launch to gain the competitive edge in the market. 

Key Players:

Capillary blood collection devices market players include – Danaher Corporation, Abbott Laboratories, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Medtronic Plc., Novo Nordisk A S, Thermo Fisher Scientific Inc., Terumo Corporation, B. Braun Melsungen AG, HTL-STREFA S.A., Sarstedt AG & Co, Ypsomed Holding AG, Greiner Bio-One, Owen Mumford Ltd., Improve Medical, Nipro, Chengdu Rich Science Industry Co., Ltd., Weigao Group, Weihai Hongyu Medical Devices, and Medigard. Profiling them in its analysis, MRFR finds out their strategies keeping them ahead in the market competition.

Capillary Blood Collection Devices Market – Segments

The MRFR analysis is segmented into four key dynamics for the convenience of the report and enhanced understanding;

 

By Material     s                      : Comprises Glass, Plastic, and Stainless Steel, among others.

By Types of Devices   : Warming Devices, Blood Collecting Tubes & Collector, and Lancets, among others.

By End-Users              : Hospitals, Clinics, Diagnostic Centers, Home Diagnostics, and Pathology Laboratories, among others.

By Regions                              :  North America,   Europe, APAC and Rest-of-the-World.

 

The Plastic segment by the materials is projected to acquire 42.3% of the market share which will be the largest share. The segment will register 10.4% CAGR during the review period 2017–2023.

The Blood Collecting Tubes and Collector segment is expected to acquire 48.4% of the market share over the review period which will be the largest share based on the types of devices

The Lancets Segment is projected to grow at a CAGR of 10.4% between 2017–2023.

Capillary Blood Collection Devices Market – Regional Analysis

North America Capillary Blood Collection Devices market insights backed by the presence of well-established players & investments, accounts for the leading market, globally, holding the largest market share. Companies involved in the manufacturing of these devices are well capable of delivering a range of customized solutions. Furthermore, augmented uptake of software solutions for healthcare administration and availability of complimenting resources drive the market growth in the region.

Factors substantiating the market growth include growing number of patients suffering from chronic diseases & disorders that consecutively augments the demand for diagnosis, increasing demand for technologically advanced diagnosis and treatment, rising government support and high per capita health care expenditures in the region. The market value is estimated to settle at US$ 292.96 Mn. by 2023.

The Europe market stands the second largest market for capillary blood collection devices, globally, owing to the technological advancement and the augmented adoption of these devices among the healthcare providers mainly in the UK, Germany, and France coupled with the resurging economy in the region which is improving the consumers’ quality of life by increasing their purchasing power.  

The market is expected to demonstrate a healthy growth during the forecast period owing to the factors such as public & private funding for R&D, the presence of leading market players and increasing prevalence of diabetes, in the region. 

Additional factors such as the availability of advent & advanced treatment facilities & healthcare expenditures along with the growing demand for better healthcare infrastructure are fuelling the market growth in the region.  Also, factors such as the ever increasing population that is increasingly adopting the sedentary lifestyle are driving the growth of the Europe market.

The Asia Pacific market stands the third position emerging as one of the promising markets for Capillary Blood Collection Devices. Factors such as, availability of new diagnosis and treatment methods, increasing prevalence of chronic diseases like diabetes and the growing population that is increasingly gaining awareness towards the benefits of health management, foster the market growth in the region.  The APAC market is estimated to grow at 10.6% CAGR during 2017–2023.

The Middle East & Africa region, on the other hand, is expected to experience a plateau phase in the growth primarily due to the African market where lack of awareness, limited access and availability of treatment facilities are some of the factors responsible for the restricted growth. While the Middle East region is expected to a steady growth owing to the well-developed healthcare sector that is increasingly availing specialty care centers. UAE among other MEA countries draws the largest market share in the region.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America